N-Methyl-alpha-phenolsuccinimide
N-Methyl-alpha-phenolsuccinimide Brand names, N-Methyl-alpha-phenolsuccinimide Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
N-Methyl-alpha-phenolsuccinimide Brand Names Mixture
- No information avaliable
N-Methyl-alpha-phenolsuccinimide Chemical_Formula
C11H11NO2
N-Methyl-alpha-phenolsuccinimide RX_link
No information avaliable
N-Methyl-alpha-phenolsuccinimide fda sheet
N-Methyl-alpha-phenolsuccinimide msds (material safety sheet)
N-Methyl-alpha-phenolsuccinimide Synthesis Reference
No information avaliable
N-Methyl-alpha-phenolsuccinimide Molecular Weight
189.211 g/mol
N-Methyl-alpha-phenolsuccinimide Melting Point
72 oC
N-Methyl-alpha-phenolsuccinimide H2O Solubility
7020 mg/L
N-Methyl-alpha-phenolsuccinimide State
Solid
N-Methyl-alpha-phenolsuccinimide LogP
1.079
N-Methyl-alpha-phenolsuccinimide Dosage Forms
Capsules
N-Methyl-alpha-phenolsuccinimide Indication
For the treatment of epilepsy
N-Methyl-alpha-phenolsuccinimide Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
N-Methyl-alpha-phenolsuccinimide Absorption
Rapid and complete
N-Methyl-alpha-phenolsuccinimide side effects and Toxicity
No information avaliable
N-Methyl-alpha-phenolsuccinimide Patient Information
No information avaliable
N-Methyl-alpha-phenolsuccinimide Organisms Affected
Humans and other mammals
